Prof & Doc

Prof & Doc’s watercress serum is a urease-inhibiting, ammonia scavenging, anti-inflammatory, sterile watercress extract designed to counteract incontinence associated dermatitis.

In Development
Innovation Overview A sterile liquid directly extracted from Watercress (Nasturtium Officinale) which has novel urease inhibiting, ammonia scavenging and anti-inflammatory function.
Inhibits urease and scavenges ammonia with a novel anti-inflammatory function. Cosmetic trials for anti-aging, trans-epidermal water loss, redness reduction and more are currently being explored.
Current strategies against incontinence associated dermatitis are focussed on absorption and barrier function which are often ineffective. We target the primary virulence factor, urease, with a natural solution.

Please note, all product information and product resources have been provided directly by the innovator. Whilst South West AHSN attempts to validate the content, we cannot be held responsible for inaccuracies

Details

Prof & Doc’s watercress serum is the first brand and product launch from Watercress Research Ltd.

Based on 7 years of research, Professor Paul Winyard (Exeter University) and Dr Kyle Stewart (Devon GP) have created a patent pending Watercress extract with unique properties to counteract incontinence associated dermatitis (termed nappy rash in infants).

The major driver incontinence associated dermatitis is the effect of ammonia which causes an alkaline chemical burn. Ammonia is created through The activity of the bacterial urease enzyme. Prof & Doc’s watercress serum contains potent urease inhibitors naturally found in watercress, along with ammonia scavenging capability and a novel anti-inflammatory function.

The problem

Current strategies to manage incontinence associated dermatitis are outdated, focussing on absorption away from the skin, or barrier protection.

Unfortunately, the volatile ammonia gas produced through urease activity can overcome these defences.

At some point in their life, it is believed every infant will suffer at least one episode of nappy rash, leading to irritability, poor feeding, susceptibility to infection and parental stress.

In the frail and elderly population, incontinence associated dermatitis can also lead to bed sores, pain and delirium.

We are the first company to target the major virulence factor, urease, and we are able to do this with a natural product with 3 distinct features.

Evidence

- in-vitro data of our extract’s skin soothing function through Tissue viability tests using artificial skin testing through the company Labskin.

- independent verification of anti-inflammatory function from ADSL - a formulation chemistry company for the cosmetic industry

- computational 3D docking studies of some of our urease inhibitors from watercress in collaboration with the University of Bath

- Urease inhibition studies of multiple extracts carried out by York Biorenewable Development Centre.

- on-going clinical trials through ADSL

Other innovations you may be interested in

The Postpartum Pack: Postnatal Digital Course
Under initial evaluation

The Positive Birth Company

The Postpartum Pack: Postnatal Digital Course

Postpartum Digital Course - expert led workshops to support women and birthing people post birth, tackling health inequalities in maternity care.

Parkinson’s Home-Based Care
Ready for deployment

CM Digital Health Solutions

Parkinson’s Home-Based Care

Home-Based Care is an innovative care pathway for People With Parkinson's that transcends ‘standard’ models of routine outpatient care

Press Play to Rewind
Under initial evaluation

Musica Music and Wellbeing CIC

Press Play to Rewind

Press Play to Rewind is an online course delivered by Musica Music and Wellbeing CIC to support care partners to embed meaningful music into dementia care. No musical experience needed!

    Interested in this innovation?

    Get in touch with the South West AHSN Innovation Exchange team to find out more.






    Latest news

    NHS and Government back AHSNs to continue to lead innovation, under new name

    NHS and Government back AHSNs to continue to lead innovation, under new name

    Read more
    South West AHSN and innovative Devon GP practice spread new ways to tackle blood pressure

    South West AHSN and innovative Devon GP practice spread new ways to tackle blood pressure

    Read more
    Applications now open for Accelerating FemTech early-stage innovations programme 

    Applications now open for Accelerating FemTech early-stage innovations programme 

    Read more